ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice

Detalhes bibliográficos
Autor(a) principal: Moraes, Oscar Albuquerque de
Data de Publicação: 2019
Outros Autores: Flues, Karin, Scapini, Kátia Bilhar, Mostarda, Cristiano, Evangelista, Fabiana de Sant’Anna, Rodrigues, Bruno, Dartora, Daniela Ravizzoni, Fiorino, Patricia, De Angelis, Kátia, Irigoyen, Maria Claúdia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/154708
Resumo: OBJECTIVES: The present study aimed to investigate cardiovascular autonomic modulation and angiotensin II (Ang II) activity in diabetic mice that were genetically engineered to harbor two or three copies of the angiotensin-converting enzyme gene. METHODS: Diabetic and non-diabetic mice harboring 2 or 3 copies of the angiotensin-converting enzyme gene were used in the present study. Animals were divided into 4 groups: diabetic groups with two and three copies of the angiotensin-converting enzyme gene (2CD and 3CD) and the respective age-matched non-diabetic groups (2C and 3C). Hemodynamic, cardiovascular, and autonomic parameters as well as renal Ang II expression were evaluated. RESULTS: Heart rate was lower in diabetic animals than in non-diabetic animals. Autonomic modulation analysis indicated that the 3CD group showed increased sympathetic modulation and decreased vagal modulation of heart rate variability, eliciting increased cardiac sympathovagal balance, compared with all the other groups. Concurrent diabetes and either angiotensin-converting enzyme polymorphism resulted in a significant increase in Ang II expression in the renal cortex. CONCLUSION: Data indicates that a small increase in angiotensin-converting enzyme activity in diabetic animals leads to greater impairment of autonomic function, as demonstrated by increased sympathetic modulation and reduced cardiac vagal modulation along with increased renal expression of Ang II.
id USP-19_660bb541ba9c59218016975841658a5c
oai_identifier_str oai:revistas.usp.br:article/154708
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic miceRenin-angiotensin SystemAutonomic Nervous SystemRenal Angiotensin SystemMiceOBJECTIVES: The present study aimed to investigate cardiovascular autonomic modulation and angiotensin II (Ang II) activity in diabetic mice that were genetically engineered to harbor two or three copies of the angiotensin-converting enzyme gene. METHODS: Diabetic and non-diabetic mice harboring 2 or 3 copies of the angiotensin-converting enzyme gene were used in the present study. Animals were divided into 4 groups: diabetic groups with two and three copies of the angiotensin-converting enzyme gene (2CD and 3CD) and the respective age-matched non-diabetic groups (2C and 3C). Hemodynamic, cardiovascular, and autonomic parameters as well as renal Ang II expression were evaluated. RESULTS: Heart rate was lower in diabetic animals than in non-diabetic animals. Autonomic modulation analysis indicated that the 3CD group showed increased sympathetic modulation and decreased vagal modulation of heart rate variability, eliciting increased cardiac sympathovagal balance, compared with all the other groups. Concurrent diabetes and either angiotensin-converting enzyme polymorphism resulted in a significant increase in Ang II expression in the renal cortex. CONCLUSION: Data indicates that a small increase in angiotensin-converting enzyme activity in diabetic animals leads to greater impairment of autonomic function, as demonstrated by increased sympathetic modulation and reduced cardiac vagal modulation along with increased renal expression of Ang II.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-02-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/15470810.6061/clinics/2018/e246Clinics; Vol. 73 (2018); e246Clinics; v. 73 (2018); e246Clinics; Vol. 73 (2018); e2461980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/154708/150762Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessMoraes, Oscar Albuquerque deFlues, KarinScapini, Kátia BilharMostarda, CristianoEvangelista, Fabiana de Sant’AnnaRodrigues, BrunoDartora, Daniela RavizzoniFiorino, PatriciaDe Angelis, KátiaIrigoyen, Maria Claúdia2019-05-14T11:48:50Zoai:revistas.usp.br:article/154708Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-14T11:48:50Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
title ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
spellingShingle ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
Moraes, Oscar Albuquerque de
Renin-angiotensin System
Autonomic Nervous System
Renal Angiotensin System
Mice
title_short ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
title_full ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
title_fullStr ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
title_full_unstemmed ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
title_sort ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice
author Moraes, Oscar Albuquerque de
author_facet Moraes, Oscar Albuquerque de
Flues, Karin
Scapini, Kátia Bilhar
Mostarda, Cristiano
Evangelista, Fabiana de Sant’Anna
Rodrigues, Bruno
Dartora, Daniela Ravizzoni
Fiorino, Patricia
De Angelis, Kátia
Irigoyen, Maria Claúdia
author_role author
author2 Flues, Karin
Scapini, Kátia Bilhar
Mostarda, Cristiano
Evangelista, Fabiana de Sant’Anna
Rodrigues, Bruno
Dartora, Daniela Ravizzoni
Fiorino, Patricia
De Angelis, Kátia
Irigoyen, Maria Claúdia
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Moraes, Oscar Albuquerque de
Flues, Karin
Scapini, Kátia Bilhar
Mostarda, Cristiano
Evangelista, Fabiana de Sant’Anna
Rodrigues, Bruno
Dartora, Daniela Ravizzoni
Fiorino, Patricia
De Angelis, Kátia
Irigoyen, Maria Claúdia
dc.subject.por.fl_str_mv Renin-angiotensin System
Autonomic Nervous System
Renal Angiotensin System
Mice
topic Renin-angiotensin System
Autonomic Nervous System
Renal Angiotensin System
Mice
description OBJECTIVES: The present study aimed to investigate cardiovascular autonomic modulation and angiotensin II (Ang II) activity in diabetic mice that were genetically engineered to harbor two or three copies of the angiotensin-converting enzyme gene. METHODS: Diabetic and non-diabetic mice harboring 2 or 3 copies of the angiotensin-converting enzyme gene were used in the present study. Animals were divided into 4 groups: diabetic groups with two and three copies of the angiotensin-converting enzyme gene (2CD and 3CD) and the respective age-matched non-diabetic groups (2C and 3C). Hemodynamic, cardiovascular, and autonomic parameters as well as renal Ang II expression were evaluated. RESULTS: Heart rate was lower in diabetic animals than in non-diabetic animals. Autonomic modulation analysis indicated that the 3CD group showed increased sympathetic modulation and decreased vagal modulation of heart rate variability, eliciting increased cardiac sympathovagal balance, compared with all the other groups. Concurrent diabetes and either angiotensin-converting enzyme polymorphism resulted in a significant increase in Ang II expression in the renal cortex. CONCLUSION: Data indicates that a small increase in angiotensin-converting enzyme activity in diabetic animals leads to greater impairment of autonomic function, as demonstrated by increased sympathetic modulation and reduced cardiac vagal modulation along with increased renal expression of Ang II.
publishDate 2019
dc.date.none.fl_str_mv 2019-02-13
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/154708
10.6061/clinics/2018/e246
url https://www.revistas.usp.br/clinics/article/view/154708
identifier_str_mv 10.6061/clinics/2018/e246
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/154708/150762
dc.rights.driver.fl_str_mv Copyright (c) 2019 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 73 (2018); e246
Clinics; v. 73 (2018); e246
Clinics; Vol. 73 (2018); e246
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222763734007808